GO:1901647 positive regulation of synoviocyte proliferation: Signaling Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901647 describes any process that activates or increases the frequency, rate or extent of synoviocyte proliferation.
• Fibroblast-like synoviocytes (FLS) are the primary cell type whose proliferation is controlled by this process, and their hyperproliferation is a hallmark of rheumatoid arthritis (RA).
• Multiple signaling pathways drive this process, including NF-kB, PI3K/AKT/mTOR, NOTCH, and CXCL16/CXCR6.
• Non-coding RNAs such as miR-365 and lncRNA FOXD2-AS1 regulate synoviocyte proliferation by targeting IGF1 and the miR-331-3p/PIAS3 axis, respectively.
• Natural compounds like shikonin and Eucommia ulmoides extract can suppress synoviocyte proliferation, highlighting therapeutic potential.
• CRISPR-based knockout, knock-in, and overexpression models are essential to causally link specific genes to positive regulation of synoviocyte proliferation.
Description
GO:1901647, positive regulation of synoviocyte proliferation, is a Gene Ontology biological process term that encompasses any molecular event that activates or increases the frequency, rate, or extent of synoviocyte proliferation. Synoviocytes, particularly fibroblast-like synoviocytes (FLS), are resident cells of the synovial membrane that play a critical role in joint homeostasis. Under pathological conditions, their uncontrolled proliferation contributes to synovial hyperplasia, a defining feature of rheumatoid arthritis (RA) and other inflammatory joint diseases. Understanding the positive regulation of synoviocyte proliferation is therefore central to deciphering RA pathogenesis and identifying therapeutic targets. Research has identified numerous signaling pathways and regulatory molecules that positively regulate synoviocyte proliferation. For example, GRK2 activates TRAF2-NF-kB signaling to promote hyperproliferation of FLS in RA. The CXCL16/CXCR6 axis also plays a role in synoviocyte proliferation. Additionally, microRNAs and long non-coding RNAs, such as miR-365 and lncRNA FOXD2-AS1, modulate proliferative signaling through IGF1 and the miR-331-3p/PIAS3 pathway, respectively. These findings underscore the complexity of this process and the need for precise experimental models. This article provides a comprehensive overview of GO:1901647, covering its definition, key genes, regulatory mechanisms, disease associations, and state-of-the-art research methods. By integrating authoritative QuickGO data with verified PubMed literature, we aim to equip researchers with a publication-ready resource for studying positive regulation of synoviocyte proliferation.
positive regulation of synoviocyte proliferation At A Glance
| GO ID | GO:1901647 |
|---|---|
| GO term | positive regulation of synoviocyte proliferation |
| Ontology | biological_process |
| Synonym | activation of synoviocyte proliferation, up regulation of synoviocyte proliferation, up-regulation of synoviocyte proliferation, upregulation of synoviocyte proliferation |
| Definition | Any process that activates or increases the frequency, rate or extent of synoviocyte proliferation. |
| Major function | Stimulation of synoviocyte division and expansion, often in the context of synovial hyperplasia. |
| Related terms | regulation of synoviocyte proliferation (GO:1901646), negative regulation of synoviocyte proliferation (GO:1901648) |
| Key cell type | Fibroblast-like synoviocytes (FLS) |
| Disease relevance | Rheumatoid arthritis, osteoarthritis, inflammatory joint diseases |
What Is GO:1901647?
According to the Gene Ontology, GO:1901647 (positive regulation of synoviocyte proliferation) is defined as any process that activates or increases the frequency, rate or extent of synoviocyte proliferation. In other words, it includes all molecular signals and pathways that stimulate synoviocytes, especially fibroblast-like synoviocytes, to divide and multiply. This term is a child of 'regulation of synoviocyte proliferation' and is distinct from negative regulation (GO:1901648). It is used to annotate gene products that promote synoviocyte proliferation, such as growth factors, cytokines, and intracellular signaling molecules.
Why Is positive regulation of synoviocyte proliferation Important in Cell Biology?
Positive regulation of synoviocyte proliferation is critically important because excessive proliferation of fibroblast-like synoviocytes is a central pathogenic mechanism in rheumatoid arthritis (RA) and other inflammatory joint disorders. In RA, FLS acquire an aggressive, tumor-like phenotype, leading to synovial hyperplasia, cartilage destruction, and bone erosion. Understanding the molecular drivers of this process can reveal novel therapeutic targets. Moreover, many signaling pathways and non-coding RNAs that regulate synoviocyte proliferation are also implicated in cancer, making this process a valuable model for studying cell cycle control and pathological tissue growth.
• Drives synovial hyperplasia, a hallmark of rheumatoid arthritis.
• Contributes to cartilage degradation and joint destruction in RA.
• Serves as a target for anti-arthritic therapies, including natural compounds and biologics.
• Involves cross-talk with inflammatory signaling pathways such as NF-kB and PI3K/AKT/mTOR.
• Regulated by non-coding RNAs (miRNAs, lncRNAs) that can be targeted therapeutically.
• Shares molecular features with cancer cell proliferation, offering insights into tumorigenesis.
• Provides a model to study the effects of genetic variants on cell proliferation.
• Enables screening of small molecules and biologics that modulate synoviocyte growth.
• Helps elucidate the role of immune cell-derived factors in synovial expansion.
• Supports development of precision medicine approaches for RA patients.
What Happens During positive regulation of synoviocyte proliferation?
Initiation by Extracellular Signals
In simple terms: External signals tell synoviocytes to start dividing.
Positive regulation of synoviocyte proliferation begins when extracellular ligands such as cytokines, growth factors, or chemokines bind to receptors on the synoviocyte surface. For instance, the chemokine CXCL16 binds to CXCR6 on fibroblast-like synoviocytes, triggering intracellular signaling that promotes proliferation. Similarly, inflammatory cytokines present in the rheumatoid synovium can activate NF-kB signaling through GRK2-TRAF2 interactions, leading to hyperproliferation. These initial signals set the stage for downstream cascades that drive cell cycle progression.
Intracellular Signaling Cascades
In simple terms: A relay of proteins inside the cell amplifies the growth signal.
Once activated, receptors engage intracellular signaling pathways. The PI3K/AKT/mTOR pathway is a key positive regulator; for example, IGF1 signaling through PI3K/AKT/mTOR promotes synoviocyte proliferation, and its downregulation by miR-365 restrains proliferation. The NOTCH pathway also contributes: survivin activates NOTCH signaling to enhance FLS proliferation and angiogenesis-related protein expression. Additionally, the NF-kB pathway, activated by GRK2-TRAF2, drives transcription of pro-proliferative genes. These cascades converge on cell cycle regulators to promote G1/S transition.
Regulation by Non-Coding RNAs
In simple terms: Small RNA molecules fine-tune the proliferation signals.
Non-coding RNAs, including microRNAs and long non-coding RNAs, modulate positive regulation of synoviocyte proliferation. miR-365 up-regulation promotes apoptosis and restrains proliferation by downregulating IGF1 and inactivating PI3K/AKT/mTOR. Conversely, lncRNA FOXD2-AS1 promotes proliferation and invasion by regulating the miR-331-3p/PIAS3 pathway. These RNA molecules act as rheostats, either enhancing or dampening proliferative signals, and their dysregulation contributes to RA pathogenesis.
Cell Cycle Progression and Proliferation
In simple terms: The cell commits to division and multiplies.
The ultimate outcome of positive regulation is the activation of cell cycle machinery, leading to DNA synthesis and mitosis. Signaling pathways such as PI3K/AKT/mTOR and NF-kB induce cyclins and CDKs while suppressing cell cycle inhibitors. In RA FLS, this results in sustained proliferation and expansion of the synovial lining. The process is also linked to apoptosis resistance; for example, shikonin induces apoptosis and autophagy while suppressing proliferation via AMPK/mTOR/ULK-1 signaling. Thus, positive regulation of synoviocyte proliferation is tightly intertwined with survival pathways.
Feedback and Crosstalk with Other Cell Types
In simple terms: The process is influenced by neighboring cells and feedback loops.
Synoviocyte proliferation is not cell-autonomous; it is influenced by interactions with immune cells, chondrocytes, and osteoclasts. For instance, Eucommia ulmoides extract ameliorates arthritis by regulating inflammation, synoviocyte proliferation, and osteoclastogenesis in vitro and in vivo. Ferroptosis-associated biomarkers have also been linked to RA, suggesting crosstalk between cell death pathways and proliferation. These feedback mechanisms ensure that synoviocyte proliferation is context-dependent and can be modulated by the inflammatory microenvironment.
Key Genes Involved in GO:1901647 positive regulation of synoviocyte proliferation
The following genes and proteins have been experimentally implicated in the positive regulation of synoviocyte proliferation, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GRK2 | Activates TRAF2-NF-kB signaling to promote FLS hyperproliferation | Potential therapeutic target in RA; KO reduces proliferation |
| TRAF2 | Adapter protein in NF-kB pathway downstream of GRK2 | Mediates GRK2-induced proliferation |
| NF-kB | Transcription factor driving pro-proliferative and inflammatory genes | Central node in synoviocyte proliferation |
| CXCL16 | Chemokine ligand for CXCR6 | Promotes synoviocyte proliferation in RA |
| CXCR6 | Receptor for CXCL16 | Mediates CXCL16-induced proliferation |
| IGF1 | Growth factor activating PI3K/AKT/mTOR | Target of miR-365; promotes proliferation |
| PI3K | Lipid kinase activating AKT | Key pathway in synoviocyte proliferation |
| AKT | Serine/threonine kinase promoting survival and proliferation | Downstream of PI3K; inactivated by miR-365 |
| mTOR | Kinase regulating cell growth and proliferation | Inactivated by miR-365; modulated by shikonin |
| Survivin | Inhibitor of apoptosis; activates NOTCH pathway | Promotes FLS proliferation and angiogenesis |
| NOTCH | Signaling pathway regulating cell fate and proliferation | Activated by survivin in FLS |
| lncRNA FOXD2-AS1 | Long non-coding RNA sponging miR-331-3p | Promotes proliferation and invasion |
| miR-331-3p | MicroRNA targeting PIAS3 | Regulated by FOXD2-AS1 |
| PIAS3 | Protein inhibitor of activated STAT3 | Downstream effector of FOXD2-AS1/miR-331-3p axis |
| miR-365 | MicroRNA targeting IGF1 | Restrains proliferation; up-regulation promotes apoptosis |
| AMPK | Energy sensor kinase | Modulated by shikonin; affects mTOR/ULK-1 |
| ULK-1 | Autophagy-initiating kinase | Downstream of AMPK/mTOR; affected by shikonin |
How Is positive regulation of synoviocyte proliferation Regulated?
Positive regulation of synoviocyte proliferation is controlled by a complex network of signaling pathways and regulatory molecules. The PI3K/AKT/mTOR pathway is a central positive regulator; its activation by IGF1 promotes proliferation, while miR-365-mediated downregulation of IGF1 restrains it. The NF-kB pathway, activated by GRK2-TRAF2, drives transcription of pro-proliferative genes. The NOTCH pathway, activated by survivin, enhances FLS proliferation and angiogenesis. Non-coding RNAs such as lncRNA FOXD2-AS1 and miR-331-3p modulate proliferation through the PIAS3 axis. Additionally, natural compounds like shikonin can suppress proliferation by modulating AMPK/mTOR/ULK-1 signaling, and Eucommia ulmoides extract regulates inflammation and synoviocyte proliferation. These regulatory mechanisms offer multiple entry points for therapeutic intervention.
positive regulation of synoviocyte proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GRK2 | Rheumatoid arthritis | Knockout or knockdown in FLS; collagen-induced arthritis mouse model |
| CXCL16/CXCR6 | Rheumatoid arthritis | Overexpression or knockout in FLS; adjuvant-induced arthritis model |
| IGF1 | Rheumatoid arthritis | Knockout or overexpression in FLS; miR-365 mimic/inhibitor |
| Survivin | Rheumatoid arthritis, cancer | Knockdown in FLS; NOTCH inhibitor treatment |
| lncRNA FOXD2-AS1 | Rheumatoid arthritis | Knockdown or overexpression in FLS; miR-331-3p sponge |
Rheumatoid Arthritis
Rheumatoid arthritis (RA) is the most prominent disease associated with positive regulation of synoviocyte proliferation. In RA, fibroblast-like synoviocytes (FLS) undergo hyperproliferation, leading to synovial hyperplasia, pannus formation, and joint destruction. Key drivers include GRK2-TRAF2-NF-kB signaling, CXCL16/CXCR6 axis, and dysregulated non-coding RNAs such as lncRNA FOXD2-AS1. Targeting these pathways can reduce FLS proliferation and ameliorate disease in preclinical models.
Osteoarthritis
Although less studied than in RA, synoviocyte proliferation also contributes to osteoarthritis (OA) pathogenesis. Synovial inflammation and hyperplasia are common in OA, and similar signaling pathways may be involved. Ferroptosis-associated biomarkers have been identified in RA and may also play a role in OA. However, direct evidence linking GO:1901647 to OA is limited, and further research is needed.
Cancer and Tumor-like Phenotypes
The proliferative and invasive properties of RA FLS resemble those of tumor cells. For example, lncRNA FOXD2-AS1 promotes both proliferation and invasion of FLS, and survivin, an apoptosis inhibitor, is overexpressed in many cancers and promotes FLS proliferation via NOTCH. Thus, studying positive regulation of synoviocyte proliferation can provide insights into cancer biology, particularly regarding cell cycle deregulation and metastasis.
From positive regulation of synoviocyte proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GRK2 promote synoviocyte proliferation? | GRK2 knockout or knockdown in FLS; proliferation assays |
| What is the role of CXCL16/CXCR6 in synoviocyte proliferation? | CXCL16 or CXCR6 knockout/overexpression in FLS |
| How does miR-365 regulate proliferation? | miR-365 mimic/inhibitor in FLS; IGF1 3'UTR reporter |
| Does survivin activate NOTCH to drive proliferation? | Survivin knockdown; NOTCH inhibitor; overexpression |
| What is the function of lncRNA FOXD2-AS1? | FOXD2-AS1 knockout/overexpression; miR-331-3p rescue |
| Can shikonin suppress synoviocyte proliferation? | Shikonin treatment in FLS; AMPK/mTOR/ULK-1 analysis |
How to Study the positive regulation of synoviocyte proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EdU/BrdU incorporation | DNA synthesis | Quantify FLS proliferation after gene manipulation |
| CCK-8/MTT assay | Metabolic activity/cell viability | Assess proliferation and drug response |
| Western blot | Protein expression and phosphorylation | Analyze PI3K/AKT/mTOR, NF-kB, NOTCH pathways |
| Co-immunoprecipitation | Protein-protein interactions | Study GRK2-TRAF2 interaction |
| Luciferase reporter | Transcriptional activity | Measure NF-kB or 3'UTR activity |
| CRISPR knockout | Gene function loss | Validate candidate regulators of proliferation |
| RNA-seq | Transcriptome changes | Identify pathways altered by gene knockout |
| In vivo arthritis model | Joint inflammation and hyperplasia | Test therapeutic interventions |
Cell Proliferation Assays
Standard methods to measure synoviocyte proliferation include MTT, CCK-8, EdU incorporation, and BrdU assays. These assays quantify DNA synthesis or metabolic activity and are widely used to assess the effects of gene knockout, knockdown, or overexpression on FLS proliferation. For example, GRK2 knockdown reduces FLS proliferation as measured by EdU, and miR-365 up-regulation decreases proliferation in CCK-8 assays.
Molecular Signaling Analysis
Western blotting, immunoprecipitation, and luciferase reporter assays are used to dissect signaling pathways. For instance, GRK2-TRAF2-NF-kB signaling was elucidated using co-immunoprecipitation and NF-kB luciferase reporters. PI3K/AKT/mTOR activity is assessed by phosphorylation-specific antibodies, and NOTCH activation by cleavage-specific antibodies.
RNA Interference and CRISPR Screening
Loss-of-function studies using siRNA, shRNA, or CRISPR knockout are essential to establish causality. CRISPR screens can identify novel regulators of synoviocyte proliferation. For example, knockout of FOXD2-AS1 or miR-331-3p sponges can validate their roles. High-throughput CRISPR libraries enable unbiased discovery of genes that positively regulate proliferation.
In Vivo Arthritis Models
Collagen-induced arthritis (CIA) and adjuvant-induced arthritis (AIA) models in rodents are used to study synoviocyte proliferation in a physiological context. Eucommia ulmoides extract was shown to ameliorate arthritis in vivo, with reduced synoviocyte proliferation. Shikonin also suppresses arthritis in mouse models. These models allow evaluation of therapeutic candidates targeting GO:1901647.
How CRISPR Can Be Used to Study GO:1901647 positive regulation of synoviocyte proliferation
Knockout
CRISPR knockout of genes such as GRK2, CXCR6, or FOXD2-AS1 in fibroblast-like synoviocytes can definitively establish their role in positive regulation of synoviocyte proliferation. For example, GRK2 knockout reduces NF-kB activation and FLS proliferation. Knockout of CXCR6 would abolish CXCL16-induced proliferation. These models are essential for target validation.
Point Mutation
Point mutations can be introduced to study specific phosphorylation sites or functional domains. For instance, mutating key residues in GRK2 or TRAF2 could disrupt their interaction and block NF-kB signaling. Similarly, point mutations in the IGF1 receptor or PI3K catalytic domain can reveal critical residues for proliferation. These models help dissect molecular mechanisms with precision.
Knock-in
Knock-in of reporter genes (e.g., luciferase or GFP) under the control of endogenous promoters allows real-time monitoring of synoviocyte proliferation. For example, a Ki-67-GFP knock-in would enable live tracking of proliferating cells. Knock-in of disease-associated variants (e.g., in GRK2 or CXCL16) can model genetic susceptibility.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can drive high-level expression of candidate genes to test sufficiency. Overexpression of lncRNA FOXD2-AS1 promotes FLS proliferation and invasion, while overexpression of miR-365 restrains proliferation. These gain-of-function models complement knockout studies.
How EDITGENE Supports positive regulation of synoviocyte proliferation Research
Researchers studying positive regulation of synoviocyte proliferation-related genes often need to determine whether a candidate gene is causally involved in driving or restraining synoviocyte growth. This requires precise genetic manipulation, which can be achieved through CRISPR-based knockout, point mutation, knock-in, or overexpression models. EDITGENE provides a comprehensive suite of services to support such studies, from custom cell line generation to high-throughput library screening and bioinformatics analysis.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of synoviocyte proliferation research.
Frequently Asked Questions About positive regulation of synoviocyte proliferation
What is GO:1901647?
GO:1901647 is the Gene Ontology term for positive regulation of synoviocyte proliferation, defined as any process that activates or increases the frequency, rate or extent of synoviocyte proliferation.
What genes are involved in positive regulation of synoviocyte proliferation?
Key genes include GRK2, TRAF2, NF-kB, CXCL16, CXCR6, IGF1, PI3K, AKT, mTOR, survivin, NOTCH, lncRNA FOXD2-AS1, miR-331-3p, PIAS3, and miR-365.
How is synoviocyte proliferation regulated in rheumatoid arthritis?
In rheumatoid arthritis, synoviocyte proliferation is positively regulated by pathways such as GRK2-TRAF2-NF-kB, CXCL16/CXCR6, PI3K/AKT/mTOR, and NOTCH, as well as by non-coding RNAs like lncRNA FOXD2-AS1.
What cell types are involved in synoviocyte proliferation?
Fibroblast-like synoviocytes (FLS) are the primary cell type whose proliferation is regulated in the synovium. Other cells such as macrophages and osteoclasts can influence FLS proliferation through secreted factors.
What diseases are associated with positive regulation of synoviocyte proliferation?
Rheumatoid arthritis is the most strongly associated disease, characterized by synovial hyperplasia due to FLS hyperproliferation. Other inflammatory joint diseases and tumor-like conditions may also involve this process.
How can I study positive regulation of synoviocyte proliferation?
Common methods include cell proliferation assays (EdU, CCK-8), western blotting for signaling pathways, CRISPR knockout or overexpression of candidate genes, and in vivo arthritis models.
What is the role of miR-365 in synoviocyte proliferation?
miR-365 up-regulation promotes apoptosis and restrains proliferation by downregulating IGF1 and inactivating the PI3K/AKT/mTOR pathway.
How does lncRNA FOXD2-AS1 affect synoviocytes?
lncRNA FOXD2-AS1 promotes cell proliferation and invasion of fibroblast-like synoviocytes by regulating the miR-331-3p/PIAS3 pathway.
Can natural compounds inhibit synoviocyte proliferation?
Yes, shikonin suppresses rheumatoid arthritis by inducing apoptosis and autophagy via AMPK/mTOR/ULK-1 signaling, and Eucommia ulmoides extract ameliorates arthritis by regulating synoviocyte proliferation.
What CRISPR models are available for studying synoviocyte proliferation?
CRISPR knockout, point mutation, knock-in, and overexpression models can be generated in fibroblast-like synoviocytes to study genes such as GRK2, CXCR6, and FOXD2-AS1.
Conclusion
GO:1901647, positive regulation of synoviocyte proliferation, is a critical biological process in the pathogenesis of rheumatoid arthritis and other inflammatory joint diseases. The interplay of signaling pathways (NF-kB, PI3K/AKT/mTOR, NOTCH), non-coding RNAs, and environmental factors drives fibroblast-like synoviocyte hyperproliferation, leading to synovial hyperplasia and joint destruction. Understanding these mechanisms offers opportunities for therapeutic intervention, as demonstrated by natural compounds and targeted inhibitors. Advanced CRISPR-based models and bioinformatics tools are indispensable for dissecting this process and identifying novel drug targets. EDITGENE provides comprehensive services to support such research, from custom cell line generation to high-throughput screening.
References
- 1. Wang XH et al.. 2024. Shikonin suppresses rheumatoid arthritis by inducing apoptosis and autophagy via modulation of the AMPK/mTOR/ULK-1 signaling pathway.. Phytomedicine 128:155512 PMID: 38460357
- 2. Wang JY et al.. 2016. Extract from Eucommia ulmoides Oliv. ameliorates arthritis via regulation of inflammation, synoviocyte proliferation and osteoclastogenesis in vitro and in vivo.. J Ethnopharmacol 194:609-616 PMID: 27743778
- 3. Han C et al.. 2025. GRK2 activates TRAF2-NF-κB signalling to promote hyperproliferation of fibroblast-like synoviocytes in rheumatoid arthritis.. Acta Pharm Sin B 15(4):1956-1973 PMID: 40486864
- 4. Zhang X et al.. 2017. [Expression of CXCL16/CXCR6 in fibroblast-like synoviocytes in rheumatoid arthritis and its role in synoviocyte proliferation].. Beijing Da Xue Xue Bao Yi Xue Ban 49(4):663-668 PMID: 28816285
- 5. Wang X et al.. 2020. Up-regulation of miR-365 promotes the apoptosis and restrains proliferation of synoviocytes through downregulation of IGF1 and the inactivation of the PI3K/AKT/mTOR pathway in mice with rheumatoid arthritis.. Int Immunopharmacol 79:106067 PMID: 31881377
- 6. He X et al.. 2023. Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis.. Front Immunol 14:1197275 PMID: 37492576
- 7. Ma S et al.. 2021. Survivin promotes rheumatoid arthritis fibroblast-like synoviocyte cell proliferation, and the expression of angiogenesis-related proteins by activating the NOTCH pathway.. Int J Rheum Dis 24(7):922-929 PMID: 34096679
- 8. Zhao Q et al.. 2021. LncRNA FOXD2-AS1 promotes cell proliferation and invasion of fibroblast-like synoviocytes by regulation of miR-331-3p/PIAS3 pathway in rheumatoid arthritis.. Autoimmunity 54(5):254-263 PMID: 34030529
